Important safety information for people with diabetes in possession of a GlucaGen® HypoKit 15 September 2016 Novo Nordisk Pharmaceuticals Pty Ltd is recalling 4 batches of GlucaGen HypoKit in Australia. The GlucaGen HypoKit is indicated for the ‘treatment of severe hypoglycaemic reactions which may occur in the management of diabetic patients receiving insulin or oral hypoglycaemic agents’. Novo Nordisk conducted an investigation showing a small number of needles were detached from the pre-filled syringe supplied in certain batches of the GlucaGen HypoKit. To protect patient safety, Novo Nordisk is recalling all products in the affected batches from wholesalers, pharmacies and patients in Australia. The recalled GlucaGen HypoKit batch numbers are: FS6X465 FS6X536 FS6X715 FS6X891 With expiry date: 31-Aug-2017 If you are in possession of a GlucaGen HypoKit with one of the listed batch numbers, return your GlucaGen HypoKit product to your pharmacy. You will be given a free replacement GlucaGen HypoKit. To view the original TGA announcement, please visit their website: https://www.tga.gov.au/alert/glucagen-hypokit If you have any questions regarding this recall, please contact NovoCare Customer Care Centre on 1800 668 626 for further information.
Blog 29 April 2024 Getting ready for the flu season: Vaccinate, please! Having the flu vaccine means you are less likely to become infected and, if you do become infected, you are more likely to only have a mild dose of the flu. Continue Reading
Blog 26 April 2024 Measuring your blood pressure at home Do you check your blood pressure regularly at home? If so, these 13 tips can help ensure you are getting the most accurate measurements. Continue Reading
Blog 26 April 2024 Protecting yourself against Shingles and pneumococcal disease This World Immunisation Week people living with diabetes are being urged to protect themselves with current immunisations. Examples of two conditions that are important to protect against are Shingles and pneumococcal disease. Continue Reading